Literature DB >> 31624970

Measles, the need for a paradigm shift.

Emilie Javelle1,2,3, Philippe Colson4,5, Philippe Parola4,6, Didier Raoult4,5.   

Abstract

Measles vaccination schedules and targets of herd immunity have been designed according to the paradigm that the vaccine is as protective as natural infection, and the virus has remained of a single serotype over many decades. As a result, ongoing measles resurgence is mostly attributed to gaps in immunization. Using official data, we investigated the correlation between the rate of vaccine coverage reported and aggregated at the national level, and the incidence of cases. We discussed the limits of this indicator considered in isolation. We provide a literature overview of measles vaccine efficacy and failures. We questioned whether measles strains could escape the vaccine. Immunization tools and strategies for measles control deserve to be optimized in the current context.

Entities:  

Keywords:  Coverage; Efficacy; Genotype; Immunization; Measles vaccine

Mesh:

Substances:

Year:  2019        PMID: 31624970     DOI: 10.1007/s10654-019-00569-4

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  123 in total

1.  Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccinees with antibody.

Authors:  M Klingele; H K Hartter; F Adu; W Ammerlaan; W Ikusika; C P Muller
Journal:  J Med Virol       Date:  2000-09       Impact factor: 2.327

Review 2.  Biological feasibility of measles eradication.

Authors:  William J Bellini; Paul A Rota
Journal:  Virus Res       Date:  2011-09-22       Impact factor: 3.303

3.  Genetic variability and mRNA editing frequencies of the phosphoprotein genes of wild-type measles viruses.

Authors:  B Bankamp; E N Lopareva; J R Kremer; Y Tian; M S Clemens; R Patel; A L Fowlkes; J R Kessler; C P Muller; W J Bellini; P A Rota
Journal:  Virus Res       Date:  2008-05-19       Impact factor: 3.303

4.  Outbreak of measles genotype H1 in Northern Italy originated from a case imported from Southeast Asia, 2017.

Authors:  F Rovida; N Brianese; A Piralla; A Sarasini; A Girello; F Giardina; I Cassaniti; C Fornabaio; E Seminari; A Monteverdi; A Piro; M Baggieri; D Cereda; A Pan; F Magurano; F Baldanti
Journal:  Clin Microbiol Infect       Date:  2018-12-08       Impact factor: 8.067

5.  Measles in Healthcare Facilities in the United States During the Postelimination Era, 2001-2014.

Authors:  Amy Parker Fiebelkorn; Susan B Redd; David T Kuhar
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

6.  Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens.

Authors:  Kimberly B Hummel; Luis Lowe; William J Bellini; Paul A Rota
Journal:  J Virol Methods       Date:  2005-11-07       Impact factor: 2.014

7.  Antigenic Drift Defines a New D4 Subgenotype of Measles Virus.

Authors:  Miguel Ángel Muñoz-Alía; Claude P Muller; Stephen J Russell
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

8.  Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000-2005.

Authors:  A V Atrasheuskaya; M V Kulak; A A Neverov; S Rubin; G M Ignatyev
Journal:  Vaccine       Date:  2008-02-27       Impact factor: 3.641

9.  The measles outbreak in Bulgaria, 2009-2011: An epidemiological assessment and lessons learnt.

Authors:  Mark Muscat; Lili Marinova; Annette Mankertz; Nina Gatcheva; Zafira Mihneva; Sabine Santibanez; Angel Kunchev; Radosveta Filipova; Mira Kojouharova
Journal:  Euro Surveill       Date:  2016

10.  Randomized Trial of 2 Versus 1 Dose of Measles Vaccine: Effect on Hospital Admission of Children After 9 Months of Age.

Authors:  Marie Brønd; Cesario L Martins; Stine Byberg; Christine S Benn; Hilton Whittle; May-Lill Garly; Peter Aaby; Ane B Fisker
Journal:  J Pediatric Infect Dis Soc       Date:  2018-08-17       Impact factor: 3.164

View more
  7 in total

1.  Measles vaccine immune escape: Should we be concerned?

Authors:  Luojun Yang; Bryan T Grenfell; Michael J Mina
Journal:  Eur J Epidemiol       Date:  2019-11-01       Impact factor: 8.082

2.  Characterization of Vaccine Breakthrough Cases during Measles Outbreaks in Milan and Surrounding Areas, Italy, 2017-2021.

Authors:  Silvia Bianchi; Maria Gori; Clara Fappani; Giulia Ciceri; Marta Canuti; Daniela Colzani; Marco Dura; Mara Terraneo; Anna Lamberti; Melissa Baggieri; Sabrina Senatore; Marino Faccini; Fabio Magurano; Elisabetta Tanzi; Antonella Amendola
Journal:  Viruses       Date:  2022-05-17       Impact factor: 5.818

3.  Molecular Epidemiology of B3 and D8 Measles Viruses through Hemagglutinin Phylogenetic History.

Authors:  Silvia Bianchi; Marta Canuti; Giulia Ciceri; Maria Gori; Daniela Colzani; Marco Dura; Beatrice Marina Pennati; Melissa Baggieri; Fabio Magurano; Elisabetta Tanzi; Antonella Amendola
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

4.  Prevalence of measles antibodies among migrant workers in Singapore: a serological study to identify susceptible population subgroups.

Authors:  Li Wei Ang; Qi Gao; Vernon Jian Ming Lee; Yee Sin Leo; Lin Cui; Aysha Farwin; Matthias Paul Han Sim Toh; Irving Charles Boudville; Mark I-Cheng Chen; Angela Chow; Raymond Tzer-Pin Lin
Journal:  BMC Infect Dis       Date:  2022-01-25       Impact factor: 3.090

5.  Prevalence and management of rubella susceptibility in healthcare workers in Italy: A systematic review and meta-analysis.

Authors:  Francesco Paolo Bianchi; Pasquale Stefanizzi; Giusy Diella; Andrea Martinelli; Antonio Di Lorenzo; Maria Serena Gallone; Silvio Tafuri
Journal:  Vaccine X       Date:  2022-08-07

Review 6.  Breakthrough Infections: A Challenge towards Measles Elimination?

Authors:  Clara Fappani; Maria Gori; Marta Canuti; Mara Terraneo; Daniela Colzani; Elisabetta Tanzi; Antonella Amendola; Silvia Bianchi
Journal:  Microorganisms       Date:  2022-08-04

7.  Low Measles Seropositivity Rate among Thai Adolescents in the Thai National Immunization Program.

Authors:  Thanyawee Puthanakit; Suvaporn Anugulruengkitt; Piyada Angsuwatcharakon; Pornumpa Bunjoungmanee; Ekasit Kowitdamrong; Athiwat Primsirikunawut; Sukkrawan Intarakhao; Panadda Chetsonwisorn; Jiratchaya Sophonphan; Auchara Tangsathapornpong
Journal:  Vaccines (Basel)       Date:  2022-08-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.